In this episode of our mPower podcast, Shelley Callahan is joined by Mitchell's third party subject-matter expert, Chris Williamson, to learn more about the current trends and challenges in the third party market. They'll also discuss successful strategies that top-performing claims organizations are incorporating, as well as why it's crucial for organizations to secure the right third party claims foundations first in order to achieve organizational success ..read more

There’s a heightened awareness in our industry on how psychosocial factors impact an injured employee’s recovery. But what’s the best way to approach and address these issues? In the fourth and final installment of our mental health in comp podcast series, we ask Nikki Wilson and Tammy Bradly to share some best practices ..read more

None of us have gone untouched by the COVID-19 pandemic. This is especially true for frontline workers who care for the critically ill. So, in part three of our series on mental health’s impact on workers’ comp, we’re going to look at the psychosocial effects the pandemic continues to play on our society and how post-traumatic stress disorder (PTSD) has become a term used more often in our industry ..read more

In part two of our mental health podcast series, we ask Tammy Bradly and Mariellen Blue if addressing mental health in the initial assessment and throughout the claim can actually have a positive effect on claims management ..read more

In this episode, we sit down with Mitchell | Genex | Coventry experts Mariellen Blue, National Director of Case Management Services at Genex, Tammy Bradly, Vice President, Clinical Production Development at Coventry, and Nikki Wilson, Director, Pharmacy Product Development at Mitchell, to discuss the role mental health plays in workers' comp and the misconceptions around treating mental health conditions. This episode is episode one of a four part series ..read more

In 2020, the workers’ compensation and auto casualty regulatory environment was more active than ever—since the start of the COVID-19 pandemic, U.S. states have passed a multitude of executive actions and emergency regulations. As we look ahead to 2021, the industry will start to see the long-term effects of these new COVID-19 regulations. Listen to our podcast to hear our legislative and regulatory predictions for 2021 ..read more

As states continue to legalization medical and recreational marijuana, what impact might the workers’ compensation industry experience? Join us for this exciting webinar as VP of Government Affairs, Brian Allen, walks you through the latest in marijuana legislation and how it could affect workers’ compensation. Attendees will learn how various states are handling the legalization of the drug, how the drug might be used for treatment by workers’ compensation patients, and how insurers should respond on a state-by-state basis ..read more

The COVID-19 pandemic and resulting economic uncertainty could have major impacts on the workers' compensation industry. Mitchell's legislative and clinical experts discuss these potential implications, from presumption laws to changes in return-to-work strategies ..read more

Social distancing guidelines across the country have led to fewer cars on the road and, as a result, a decline in auto accidents. In California alone, accidents have decreased by about half since instituting shelter-in-place restrictions, according to a UC Davis study. To learn more about the changes on the road and in the auto insurance industry overall, we sat down with Mitchell’s auto casualty and auto physical damage experts: * Debbie Day, Mitchell Auto Physical Damage executive vice president and general manager shares her thoughts about how the pandemic is prompting the auto insurance in ..read more

In this podcast, Mitchell | Genex subject matter experts from across the business share their expertise on how the COVID-19 pandemic is affecting—and will continue to influence—many different areas of the workers’ compensation claims process. Hear from the following Mitchell | Genex leaders: * Michele Hibbert-Iacobacci, Mitchell senior vice president of regulatory compliance management, discusses regulatory updates, telemedicine trends and more. * Dr. Mitch Freeman, Mitchell senior vice president and chief clinical officer, explains current and potential pharmacy impacts. * Pat Chavanu,   ..read more